108 related articles for article (PubMed ID: 659559)
1. Determination of the ophthalmic therapeutic pilocarpine and its degradation products by reversed-phase high-performance liquid chromatography.
Noordam A; Waliszewski K; Olieman C; Maat L; Beyerman HC
J Chromatogr; 1978 Jun; 153(1):271-3. PubMed ID: 659559
[No Abstract] [Full Text] [Related]
2. Quantitative determination of pilocarpine, isopilocarpine, pilocarpic acid, and isopilocarpic acid in clinical ophthalmic pilocarpine formulations by reversed-phase liquid chromatography.
Noordam A; Maat L; Beyerman HC
J Pharm Sci; 1981 Jan; 70(1):96-7. PubMed ID: 7229939
[TBL] [Abstract][Full Text] [Related]
3. Analysis of pilocarpine and isopilocarpine in ophthalmic solutions by normal-phase high-performance liquid chromatography.
Dunn DL; Scott BS; Dorsey ED
J Pharm Sci; 1981 Apr; 70(4):446-9. PubMed ID: 7229964
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic analysis of pilocarpine hydrochloride, isopilocarpine, pilocarpic acid and isopilocarpic acid in eye-drop preparations.
Kennedy JM; McNamara PE
J Chromatogr; 1981 Aug; 212(3):331-8. PubMed ID: 7263802
[TBL] [Abstract][Full Text] [Related]
5. Determination of pilocarpine, physostigmine, its degradation product rubreserine and preservatives by high-performance liquid chromatography.
Kneczke M
J Chromatogr; 1980 Oct; 198(4):529-33. PubMed ID: 7440688
[No Abstract] [Full Text] [Related]
6. Separation and analysis of pilocarpine, isopilocarpine, and pilocarpic acid by reverse phase liquid chromatography: collaborative study.
Van Ackeren JL; Venable RM; Wainer IW
J Assoc Off Anal Chem; 1984; 67(5):924-6. PubMed ID: 6501156
[TBL] [Abstract][Full Text] [Related]
7. Analysis of commercial pilocarpine preparations by high-performance liquid chromatography.
Drake MV; O'Donnell JJ; Sandman RP
J Pharm Sci; 1982 Mar; 71(3):358-9. PubMed ID: 7069599
[No Abstract] [Full Text] [Related]
8. Pilocarpine hydrochloride in ophthalmic solutions: modification of a high-pressure liquid chromatographic determination and survey.
Weber JD
J Assoc Off Anal Chem; 1976 Nov; 59(6):1409-15. PubMed ID: 993193
[TBL] [Abstract][Full Text] [Related]
9. [The stability of pilocarpine hydrochloride in eyedrops].
Porst H; Kny L
Pharmazie; 1985 Jan; 40(1):23-9. PubMed ID: 3991781
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic determination of pilocarpine hydrochloride and its degradation products using a beta-cyclodextrin column.
Sternitzke KD; Fan TY; Dunn DL
J Chromatogr; 1992 Jan; 589(1-2):159-64. PubMed ID: 1541661
[TBL] [Abstract][Full Text] [Related]
11. [Determination of pilocarpine and isopilocarpine by high performance liquid chromatography in normal phase. The stability of eye drops with a pilocarpine base and comparison of this method with a colorimetric method using hydroxylamine].
Balansard G; Vidal E; Guigues M; Ollivier B; de Meo M
Pharm Acta Helv; 1986; 61(2):47-50. PubMed ID: 3960937
[No Abstract] [Full Text] [Related]
12. Effect of sterilization by autoclaving on the stability of eye drops of pilocarpine hydrochloride and physostigmine sulphate.
Mair AE; Miller JH
J Clin Hosp Pharm; 1984 Sep; 9(3):217-24. PubMed ID: 6490942
[TBL] [Abstract][Full Text] [Related]
13. Measurement of pilocarpine and its degradation products by high-performance liquid chromatography.
O'Donnell JJ; Sandman R; Drake MV
J Pharm Sci; 1980 Sep; 69(9):1096-7. PubMed ID: 7411418
[TBL] [Abstract][Full Text] [Related]
14. Decomposition of pilocarpine eye drops assessed by a highly efficient high pressure liquid chromatographic method.
Kuks PF; Weekers LE; Goldhoorn PB
Pharm Weekbl Sci; 1990 Oct; 12(5):196-9. PubMed ID: 2255589
[TBL] [Abstract][Full Text] [Related]
15. High-speed liquid chromatographic determination of pilocarpine in pharmaceutical dosage forms.
Khalil SK
J Pharm Sci; 1977 Nov; 66(11):1625-6. PubMed ID: 915743
[TBL] [Abstract][Full Text] [Related]
16. [Stability and determination of pilocarpine in eyedrops].
Jacob M; Duru M; Duru C
Pharm Acta Helv; 1981; 56(2):59-63. PubMed ID: 7220561
[No Abstract] [Full Text] [Related]
17. Stability of pilocarpine ophthalmic formulations.
Yoshioka S; Aso Y; Shibazaki T; Uchiyama M
Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4280-6. PubMed ID: 3829160
[No Abstract] [Full Text] [Related]
18. Determination of pilocarpine, isopilocarpine, pilocarpic acid and isopilocarpic acid in human plasma and urine by high-performance liquid chromatography with tandem mass spectrometric detection.
van de Merbel NC; Tinke AP; Oosterhuis B; Jonkman JH; Bohle JF
J Chromatogr B Biomed Sci Appl; 1998 Apr; 708(1-2):103-12. PubMed ID: 9653952
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of degradation products in pilocarpine hydrochloride ophthalmic formulations.
Neville GA; Hasan FB; Smith IC
J Pharm Sci; 1977 May; 66(5):638-42. PubMed ID: 17713
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic assay for pilocarpine in aqueous humor.
Rendi MA; Ellis PP; Gal J
J Chromatogr; 1984 Dec; 336(2):337-44. PubMed ID: 6530466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
